Chennavasin P, Johnson R A, Brater D C
J Pharmacokinet Biopharm. 1981 Oct;9(5):623-33. doi: 10.1007/BF01061029.
The pharmacokinetics of furosemide in normal man reported from a number of investigators show great discrepancies. We have evaluated the effect on derived pharmacokinetic parameters of furosemide of using different weighting factors or fewer data points to fit the same set of data to an exponential equation, or using noncompartmental analysis. Terminal half-lives of furosemide differed vastly, as did the volume of distribution, but to a lesser extent. The plasma clearance was rather consistent with the different methods used. Thus the discrepancies of the pharmacokinetics of furosemide may, in large part, be due to different methods of analysis of the data. The terminal half-life was most subject to errors of method and the plasma clearance the least.
许多研究者报告的呋塞米在正常人体内的药代动力学存在很大差异。我们评估了使用不同加权因子或较少数据点将同一组数据拟合到指数方程,或使用非房室分析对呋塞米衍生药代动力学参数的影响。呋塞米的末端半衰期差异极大,分布容积也是如此,但程度较小。血浆清除率在使用的不同方法中较为一致。因此,呋塞米药代动力学的差异在很大程度上可能归因于不同的数据分析法。末端半衰期最容易受到方法误差的影响,而血浆清除率受影响最小。